New prostate cancer treatment doubles survival rates

A 10-year study has discovered a new treatment approach that doubles the survival chances of men with locally advanced prostate cancer. The University of Newcastle study shows combining radiotherapy with six months of hormone therapy significantly reduces the death rate of prostate cancer patients. Researchers found the rate of prostate cancer death for men receiving radiotherapy with six months’ hormone therapy was reduced to 11 per cent, compared to 22 per cent for men receiving radiotherapy alone.

Read more at University of Newcastle